Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.39 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 2/20 | 0.37 |
| ▸ | NOS1 | P29475 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42306 | 1.00 | BCAT2 (0.43) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7459500 | 1.00 | BCAT2 (0.43) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| Hydrochloric Acid SCHEMBL5706571 | 0.98 | BCAT2 (0.42) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| Hydrochloric Acid SCHEMBL8426381 | 0.98 | BCAT2 (0.42) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| Hydrochloric Acid SCHEMBL5706573 | 0.98 | BCAT2 (0.42) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| Carbamic Acid SCHEMBL7780891 | 0.97 | BCAT2 (0.44) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| Carbamic Acid SCHEMBL7455331 | 0.97 | BCAT2 (0.44) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| Valine SCHEMBL7460247 | 0.87 | SLC1A3 (0.41) | BCAT2ALPIPKMPTGS1XIAP | |
| SCHEMBL29773094 | 0.82 | SCN9A (0.44) | BCAT2KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL7027775 | 0.82 | EPHX1 (0.36) | ALPIPKMPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239740-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | SK BIOPHARMACEUTICALS CO LTD (KR) | 2024-07-18 | — | — | US | claimed |
| US-20210078943-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | SK BIOPHARMACEUTICALS CO LTD (KR) | 2021-03-18 | — | — | US | claimed |
| EP-1890684-B1 | Treatment of sleep-wake disorders | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-14 | — | — | EP | claimed |
| US-20090312416-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | SK HOLDINGS CO., LTD. (KR) | 2009-12-17 | — | — | US | claimed |
| EP-1890684-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | SK Holdings Co., Ltd. (KR) | 2008-02-27 | — | — | EP | claimed |
| WO-2006133393-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | SK HOLDINGS CO., LTD. (KR) | 2006-12-14 | — | — | WO | claimed |
| EP-0873308-B1 | O-CARBAMOYL-PHENYLALANINOL COMPOUNDS AND THEIR PHARMACEUTICALLY USEFUL SALTS | SK CORP (KR) | 2002-01-02 | — | — | EP | claimed |
| EP-0815074-B1 | O-CARBAMOYL-(D)-PHENYLALANILOL COMPOUNDS AND PROCESS FOR PREPARING THE SAME | SK CORP (KR) | 2001-10-04 | — | — | EP | claimed |
| EP-0820438-B1 | O-CARBAMOYL-PHENYLALANINOL HAVING SUBSTITUENT AT BENZENE RING, ITS PHARMACEUTICALLY USEFUL SALTS AND METHOD FOR PREPARING THE SAME | SK CORP (KR) | 2001-06-20 | — | — | EP | claimed |
| US-6140532-A | O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same | SK CORPORATION (US) | 2000-10-31 | — | — | US | claimed |
| EP-0873308-A1 | O-CARBAMOYL-PHENYLALANINOL COMPOUNDS, THEIR PHARMACEUTICALLY USEFUL SALTS AND PROCESS FOR PREPARING THE SAME | SK Corporation (KR) | 1998-10-28 | — | — | EP | claimed |
| US-5756817-A | TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEMS | YUKONG LIMITED (KR) | 1998-05-26 | — | — | US | claimed |
| WO-1998015526-A1 | O-CARBAMOYL-PHENYLALANINOL COMPOUNDS, THEIR PHARMACEUTICALLY USEFUL SALTS AND PROCESS FOR PREPARING THE SAME | SK CORPORATION (KR) | 1998-04-16 | — | — | WO | claimed |
| EP-0820438-A1 | O-CARBAMOYL-PHENYLALANINOL HAVING SUBSTITUENT AT BENZENE RING, ITS PHARMACEUTICALLY USEFUL SALTS AND METHOD FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1998-01-28 | — | — | EP | claimed |
| EP-0815074-A1 | O-CARBAMOYL-(D)-PHENYLALANILOL COMPOUNDS AND PROCESS FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1998-01-07 | — | — | EP | claimed |
| US-5705640-A | O-carbamoyl-(d)-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same | YUKONG LIMITED (KR) | 1998-01-06 | — | — | US | claimed |
| WO-1996032375-A1 | O-CARBAMOYL-PHENYLALANINOL HAVING SUBSTITUENT AT BENZENE RING, ITS PHARMACEUTICALLY USEFUL SALTS AND METHOD FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-10-17 | — | — | WO | claimed |
| EP-0728129-A1 | NOVEL PHENYLALKYLAMINOALCOHOL CARBAMATES AND PROCESS FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-08-28 | — | — | EP | claimed |
| WO-1996024577-A1 | O-CARBAMOYL-(D)-PHENYLALANILOL COMPOUNDS AND PROCESS FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-08-15 | — | — | WO | claimed |
| WO-1996007637-A1 | NOVEL PHENYLALKYLAMINOALCOHOL CARBAMATES AND PROCESS FOR PREPARING THE SAME | YUKONG LIMITED (KR) | 1996-03-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239740-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | HCRTR1, HCRTR2, MTNR1B | BCAT2 1196/4885KDM4E 721/4885ALDH1A1 1565/4885 |
| US-20210078943-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | HCRTR1, HCRTR2, MTNR1B | BCAT2 1196/4885KDM4E 721/4885ALDH1A1 1565/4885 |
| US-20090312416-A1 | TREATMENT OF SLEEP-WAKE DISORDERS | HCRTR1, HCRTR2, MTNR1B | BCAT2 1196/4885KDM4E 721/4885ALDH1A1 1565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.